Does SEMUSTINE Cause Product use in unapproved indication? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Product use in unapproved indication have been filed in association with SEMUSTINE. This represents 10.3% of all adverse event reports for SEMUSTINE.
16
Reports of Product use in unapproved indication with SEMUSTINE
10.3%
of all SEMUSTINE reports
9
Deaths
0
Hospitalizations
How Dangerous Is Product use in unapproved indication From SEMUSTINE?
Of the 16 reports, 9 (56.3%) resulted in death.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SEMUSTINE. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does SEMUSTINE Cause?
Pneumonia (25)
Febrile neutropenia (21)
Cystitis haemorrhagic (14)
Drug ineffective (14)
Off label use (13)
Complications of bone marrow transplant (12)
Infection (12)
Post transplant lymphoproliferative disorder (12)
Pulmonary alveolar haemorrhage (12)
Gastrointestinal disorder (11)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which SEMUSTINE Alternatives Have Lower Product use in unapproved indication Risk?
SEMUSTINE vs SENNA LEAF
SEMUSTINE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMUSTINE vs SENNOSIDES
SEMUSTINE vs SENNOSIDES A AND B
SEMUSTINE vs SENSIPAR